The proposed sale is de minimis and likely routine portfolio management by a venture investor. No material impact on stock expected. Monitor for any subsequent Form 4 filings to confirm execution.
Price Chart
Executive Summary
Atlas Venture Fund XII, L.P., a major venture capital shareholder of Disc Medicine (IRON), filed a Form 144 notice of intent to sell 266 shares of common stock, with an estimated aggregate market value of approximately $21,141.68. The shares were acquired in a private placement on May 1, 2020. This is a very small proposed sale relative to the fund's likely total holdings and the company's market cap, and is likely a routine portfolio adjustment.
Key Facts
- Atlas Venture Fund XII, L.P. filed Form 144 to sell 266 shares of Disc Medicine common stock.
- Estimated aggregate market value of the proposed sale is approximately $21,141.68.
- Shares were acquired in a private placement on May 1, 2020.
- The filing is an advance notice of intent to sell; the sale may not occur.
Financial Impact
Proposed sale of 266 shares valued at ~$21,142, a negligible amount relative to the company's market cap and the fund's holdings.
Risk Factors
- Insider selling could signal reduced conviction, but the amount here is too small to be meaningful.
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001628280-26-066745 |
| Document: 0001628280-26-066745-index.html | 0001628280-26-066745 |
| Document: 0001628280-26-066745.txt | 0001628280-26-066745 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 1d ago | SC 13D/A | $77.66 | awaiting T+20 | awaiting T+20 | $82.36 (+6.05%) |
Oct 22, 2026 5d ago | 8-K | $74.51 | awaiting T+20 | awaiting T+20 | $82.36 (−10.53%) |
Oct 21, 2026 6d ago | 424B5 | $75.03 | awaiting T+20 | awaiting T+20 | $82.36 (−9.76%) |
Oct 21, 2026 6d ago | 144 | $75.03 | awaiting T+20 | awaiting T+20 | $82.36 (+9.76%) |
Oct 21, 2026 6d ago | 144 | $75.03 | awaiting T+20 | awaiting T+20 | $82.36 (+9.76%) |
Oct 21, 2026 6d ago | 144 | $75.03 | awaiting T+20 | awaiting T+20 | $82.36 (+9.76%) |
Oct 20, 2026 7d ago | 144 | $76.00 | awaiting T+20 | awaiting T+20 | $82.36 (+8.36%) |
Oct 20, 2026 7d ago | 144 | $76.00 | awaiting T+20 | awaiting T+20 | $82.36 (+8.36%) |
Oct 20, 2026 7d ago | 144 | $76.00 | awaiting T+20 | awaiting T+20 | $82.36 (+8.36%) |
Oct 19, 2026 8d ago | 424B5 | $79.48 | awaiting T+20 | awaiting T+20 | $82.36 (−3.62%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers